These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28235514)

  • 21. Case report: management of differential diagnosis and treatment of severe anaphylaxis in the setting of spinal anesthesia.
    Osman BM; Maga JM; Baquero SM
    J Clin Anesth; 2016 Dec; 35():145-149. PubMed ID: 27871512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early skin and challenge testing after rocuronium anaphylaxis.
    Schulberg EM; Webb AR; Kolawole H
    Anaesth Intensive Care; 2016 May; 44(3):425-7. PubMed ID: 27246945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
    Whalley DG; Maurer WG; Knapik AL; Estafanous FG
    Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model.
    Clarke RC; Sadleir PH; Platt PR
    Anaesthesia; 2012 Mar; 67(3):266-73. PubMed ID: 22321083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Rocuronium-induced Anaphylaxis in Which Surgery was Subsequently Performed under General Anesthesia without Neuromuscular Blocking Agents].
    Horiuchi T; Takazawa T; Saito S
    Masui; 2016 Mar; 65(3):299-303. PubMed ID: 27097513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of skin tests for the choice of a neuromuscular blocking agent after an anaphylactic reaction].
    Dewachter P; Mouton-Faivre C; Pertek JP; Boudaa C; Mertes PM
    Ann Fr Anesth Reanim; 2005 May; 24(5):543-6. PubMed ID: 15904734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 28. Anaphylaxis to rocuronium.
    Baillard C; Korinek AM; Galanton V; Le Manach Y; Larmignat P; Cupa M; Samama CM
    Br J Anaesth; 2002 Apr; 88(4):600-2. PubMed ID: 12066744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast-track anesthesia in patients undergoing outpatient laparoscopic cholecystectomy: comparison of sevoflurane with total intravenous anesthesia.
    Çaparlar CÖ; Özhan MÖ; Süzer MA; Yazicioğlu D; Eşkin MB; Şenkal S; Çaparlar MA; Imren EÖ; Atik B; Çekmen N
    J Clin Anesth; 2017 Feb; 37():25-30. PubMed ID: 28235523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apropos of drug allergy].
    Sabbah A
    Allerg Immunol (Paris); 1996 Sep; 28(7):230, 233. PubMed ID: 8983238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study.
    Platt PR; Clarke RC; Johnson GH; Sadleir PH
    Anaesthesia; 2015 Nov; 70(11):1264-7. PubMed ID: 26259130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anaphylaxis after rocuronium: advantage of blood tests for early diagnosis].
    Joseph P; Benoit Y; Gressier M; Blanc P; Lehot JJ
    Ann Fr Anesth Reanim; 2002 Mar; 21(3):221-3. PubMed ID: 11963386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A subhypnotic dose of ketamine reduces pain associated with injection of propofol and rocuronium.
    Abduşoğlu MN; Özkoçak I; Yurtlu BS; Hancı V; Okyay RD; Ayoğlu H
    Eur J Anaesthesiol; 2011 Mar; 28(3):229-30. PubMed ID: 21157354
    [No Abstract]   [Full Text] [Related]  

  • 35. [Severe anaphylaxis from rocuronium].
    Kubitz JC; Krause T; Dietz R; Friederich P; Goetz AE
    Anaesthesist; 2006 Nov; 55(11):1169-71. PubMed ID: 16924517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rocuronium-induced anaphylaxis. Potential off-label use of sugammadex].
    Silva-Obregón JA; Gamero-Donis D; Romo-Gonzales JE; Benito-Puncel C; Borrallo-Pérez JM; Marian-Crespo C
    Med Intensiva; 2014; 38(1):58-9. PubMed ID: 23375690
    [No Abstract]   [Full Text] [Related]  

  • 37. [A case of rocuronium-induced anaphylactic shock, improved by sugammadex].
    Badaoui R; Popov I; Dupont H
    Can J Anaesth; 2012 Sep; 59(9):909-10. PubMed ID: 22653841
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of anesthesia on hemodynamic and volume changes in operative hysteroscopy: a bioimpedance randomized study.
    Moharram EE; El Attar AM; Kamel MA
    J Clin Anesth; 2017 May; 38():59-67. PubMed ID: 28372680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prick testing for neuromuscular blocking drugs.
    Dhonneur G
    Anesth Analg; 2004 Dec; 99(6):1880-1881. PubMed ID: 15562106
    [No Abstract]   [Full Text] [Related]  

  • 40. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique.
    Berg CM; Heier T; Wilhelmsen V; Florvaag E
    Acta Anaesthesiol Scand; 2003 May; 47(5):576-82. PubMed ID: 12699516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.